174 related articles for article (PubMed ID: 10354036)
1. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy.
González-López A; Velasco E; Pozo T; Del Villar A
Br J Dermatol; 1999 May; 140(5):931-4. PubMed ID: 10354036
[TBL] [Abstract][Full Text] [Related]
2. Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne.
Martin AG; Weaver CC; Cockerell CJ; Berger TG
Br J Dermatol; 1992 Jun; 126(6):617-20. PubMed ID: 1535216
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
[TBL] [Abstract][Full Text] [Related]
4. Pityriasis rubra pilaris and human immunodeficiency virus infection.
Miralles ES; Núñez M; De Las Heras ME; Pérez B; Moreno R; Ledo A
Br J Dermatol; 1995 Dec; 133(6):990-3. PubMed ID: 8547057
[TBL] [Abstract][Full Text] [Related]
5. Severe, Disfiguring, Pityriasis Rubra Pilaris in a Woman in the Dominican Republic: Histopathologic Diagnosis and Response to Antiretroviral Therapy.
Lerebours-Nadal L; Beck-Sague CM; Parker D; Gosman A; Saavedra A; Engel K; Dean AG
J Int Assoc Provid AIDS Care; 2016; 15(1):11-4. PubMed ID: 26514629
[TBL] [Abstract][Full Text] [Related]
6. First clinical data presented on FortovAse.
AIDS Patient Care STDS; 1997 Dec; 11(6):455. PubMed ID: 11361868
[No Abstract] [Full Text] [Related]
7. Pityriasis rubra pilaris and HIV infection.
Blauvelt A; Nahass GT; Pardo RJ; Kerdel FA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):703-5. PubMed ID: 1869640
[TBL] [Abstract][Full Text] [Related]
8. Data in from first head-to-head protease inhibitor.
AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
[No Abstract] [Full Text] [Related]
9. The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
Jensen-Fangel S; Kirk O; Blaxhult A; Gerstoft J; Pedersen C; Black FT; Lundgren JD; Obel N
HIV Clin Trials; 2001; 2(2):122-7. PubMed ID: 11590520
[TBL] [Abstract][Full Text] [Related]
10. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
[TBL] [Abstract][Full Text] [Related]
11. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.
Hengge UR; Goos M; Esser S; Exner V; Dötterer H; Wiehler H; Borchard C; Müller K; Beckmann A; Eppner MT; Berger A; Fiedler M
AIDS; 1998 Dec; 12(17):F225-34. PubMed ID: 9863864
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
[TBL] [Abstract][Full Text] [Related]
13. Pityriasis rubra pilaris in a HIV-positive patient (Type 6 PRP).
De D; Dogra S; Narang T; Radotra BD; Kanwar AJ
Skinmed; 2008; 7(1):47-50. PubMed ID: 18174806
[TBL] [Abstract][Full Text] [Related]
14. Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine.
Hurni MA; Böhlen L; Furrer H; Braathen LR
AIDS; 1997 Nov; 11(14):1784-5. PubMed ID: 9386818
[No Abstract] [Full Text] [Related]
15. Double protease inhibitor regimens with amprenavir show promise.
AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
[No Abstract] [Full Text] [Related]
16. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
[No Abstract] [Full Text] [Related]
17. Pityriasis rubra pilaris with preceding cytomegalovirus infection.
Kawara S; Miyake M; Oiso N; Kawada A
Dermatology; 2009; 219(4):350-2. PubMed ID: 19776541
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
[TBL] [Abstract][Full Text] [Related]
19. Adult onset pityriasis rubra pilaris.
Sehgal VN; Srivastava G; Dogra S
Indian J Dermatol Venereol Leprol; 2008; 74(4):311-21. PubMed ID: 18797049
[TBL] [Abstract][Full Text] [Related]
20. A review of pityriasis rubra pilaris and rheumatologic associations.
Chan H; Liu FT; Naguwa S
Clin Dev Immunol; 2004 Mar; 11(1):57-60. PubMed ID: 15154613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
